Nucleic Acids Research, 1990, Vol. 18, No. 3 465-470
© 1990
MOLECULAR BIOLOGY |
Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers
Institute of Molecular and Cell Biology, National University of Singapore Kent Ridge, 0511 Singapore
* To whom correspondence should be addressed
Received November 6, 1989. Revised January 2, 1990. Accepted January 2, 1990.
Human papillomavirus 16 (HPV-16), which is involved in genital carcinogenesis, contains an enhancer of transcription that is activated by cellular factors rather than by the viral E2 proteins. The activity resides on a 232 bp segment with 5 binding sites for nuclear factor 1 (NFl), 2 for AP1, and 1 for steroid receptors. Deletions and point mutations show that the constitutive enhancer and the steroid response depend on NF1 sites located 5' or 3' of a 65 bp fragment with AP1 sites that by itself shows little activity. Enhancement through a fragment with AP1 and NF1 sites is strongly reduced by mutation of the AP1 sites, or by mutation of the sequence AGGCACATAT. Sequence comparison and footprint analysis make it likely that this sequence binds a novel transcription factor which we call PVF. Fragments with one or several binding sites only for NF1, or AP1, or PVF exhibit little enhancement by themselves, suggesting the functional dependence of the HPV-16 enhancer on the cooperation of these factors. A comparison of our findings with the genomes and transcription factor binding sites of HPV-6, 11, 18, 31 and 33 lead us to propose a model of the composition of enhancers of genital papillomaviruses.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Kessler, G. Sezonov, J. I. Guijarro, N. Desnoues, T. Rose, M. Delepierre, S. D. Bell, and D. Prangishvili A novel archaeal regulatory protein, Sta1, activates transcription from viral promoters Nucleic Acids Res., October 18, 2006; 34(17): 4837 - 4845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Baldwin, L. Pirisi, and K. E. Creek NFI-Ski Interactions Mediate Transforming Growth Factor {beta} Modulation of Human Papillomavirus Type 16 Early Gene Expression J. Virol., April 15, 2004; 78(8): 3953 - 3964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Norwitz, S. Xu, J. Xu, L. B. Spiryda, J. S. Park, K.-H. Jeong, E. A. McGee, and U. B. Kaiser Direct Binding of AP-1 (Fos/Jun) Proteins to a SMAD Binding Element Facilitates Both Gonadotropin-releasing Hormone (GnRH)- and Activin-mediated Transcriptional Activation of the Mouse GnRH Receptor Gene J. Biol. Chem., September 27, 2002; 277(40): 37469 - 37478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kämmer, U. Warthorst, N. Torrez-Martinez, C. M. Wheeler, and H. Pfister Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity J. Gen. Virol., August 1, 2000; 81(8): 1975 - 1981. [Abstract] [Full Text]
|
|
|
|
|
|
H. Lewis, K. Webster, A.-M. Sanchez-Perez, and K. Gaston Cellular transcription factors regulate human papillomavirus type 16 gene expression by binding to a subset of the DNA sequences recognized by the viral E2 protein J. Gen. Virol., August 1, 1999; 80(8): 2087 - 2096. [Abstract] [Full Text]
|
|
|
|
|
|
P. H. Bednarek, B. J. Lee, S. Gandhi, E. Lee, and B. Phillips Novel Binding Sites for Regulatory Factors in the Human Papillomavirus Type 18 Enhancer and Promoter Identified by In Vivo Footprinting J. Virol., January 1, 1998; 72(1): 708 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Thain, K. Webster, D. Emery, A. R. Clarke, and K. Gaston DNA Binding and Bending by the Human Papillomavirus Type 16E2 Protein. RECOGNITION OF AN EXTENDED BINDING SITE J. Biol. Chem., March 28, 1997; 272(13): 8236 - 8242. [Abstract] [Full Text] [PDF]
|
|